| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Director, 10% Owner
3 companies
Bolzon Bradley J Phd is a Director, 10% Owner at Monte Rosa Therapeutics, Inc. with holdings across 3 companies. Recent SEC Form 4 filings include 1 buy and 77 sells.
Estimated insider holdings value: $49.9M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 19, 2021 | CRSP Crispr Therapeutics AG | Director | Sell | 10,000 | $126.43 | $1,264,347.53 | -1.6% | -23.5% | -33.4% | |
| Jun 29, 2021 | CRSP Crispr Therapeutics AG | Director | Sell | 47,536 | $149.49 | $7,106,341.02 | -20.0% | -22.1% | -58.1% | |
| Jun 28, 2021 | CRSP Crispr Therapeutics AG | Director | Sell | 30,375 | $152.48 | $4,631,582.53 | -2.5% | -22.7% | -58.3% | |
| Jun 28, 2021 | GLUE Monte Rosa Therapeutics, Inc. | Director, 10% Owner | Buy | 157,895 | $19.00 | $3,000,005.00 | +8.1% | +28.8% | -49.9% | |
| Jun 11, 2021 | CRSP Crispr Therapeutics AG | Director | Sell | 10,000 | $126.61 | $1,266,118.41 | -8.2% | -4.4% | -49.8% | |
| Mar 22, 2021 | CRSP Crispr Therapeutics AG | Director | Sell | 30,374 | $132.37 | $4,020,666.79 | -9.1% | -2.5% | -49.2% | |
| Feb 19, 2021 | CRSP Crispr Therapeutics AG | Director | Sell | 171,003 | $149.11 | $25,497,839.62 | -14.1% | - | - | |
| Dec 16, 2020 | CRSP Crispr Therapeutics AG | Director | Sell | 15,000 | $148.95 | $2,234,265.51 | -0.9% | - | - | |
| Dec 10, 2020 | CRSP Crispr Therapeutics AG | Director | Sell | 33,000 | $143.35 | $4,730,447.90 | -1.9% | - | - | |
| Dec 7, 2020 | CRSP Crispr Therapeutics AG | Director | Sell | 171,004 | $154.53 | $26,424,505.04 | -2.0% | - | - |